Skip to the answer

Ezetimibe / Simvastatin Uses, Dosage, Side Effects and Interactions

Brand name
Vytorin

Vytorin was the first ezetimibe / simvastatin product the FDA approved, in July 2004. An FDA-approved generic with the same active ingredients is listed.

Ezetimibe / Simvastatin is a two-in-one cholesterol medicine, taken as a tablet, that lowers LDL (“bad”) cholesterol in people with high cholesterol, including inherited forms, alongside a healthy diet.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About Ezetimibe / SimvastatinType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Ezetimibe / Simvastatin in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Ezetimibe/simvastatin (Vytorin) lowers LDL (“bad”) cholesterol, including in inherited forms of high cholesterol, by pairing ezetimibe, which blocks cholesterol absorption in the gut, with simvastatin, a statin that slows the liver’s own cholesterol production; it is usually an add-on step when a statin alone falls short, on the U.S. market since about 2004 with FDA-approved generics listed. Most people tolerate it well, and the side effects noticed most are headache, muscle aches and diarrhea. The one thing to watch for is unexplained muscle pain, tenderness or weakness, especially with fever, since it can rarely signal rhabdomyolysis, a serious muscle breakdown that can harm the kidneys.

Key Takeaways From the HelloPharmacist Team

  • Take it once each evening, with or without food; a missed dose is taken when remembered, never doubled.
  • Avoid grapefruit juice and have every new prescription checked against it; some antibiotics, antifungals and heart medicines clash or require a lower dose.
  • Expect a liver blood test before starting and later as needed, and report yellowing of the skin or eyes promptly.
  • Use effective birth control if you could become pregnant, and stop it and call your prescriber right away if pregnancy happens.

How we write and review this content: our editorial policy

Ezetimibe / Simvastatin by the Numbers

Strengths
4
in one form
Makers and packagers
8
Earliest FDA record
2004
Rank by Medicaid prescriptions
#1,145 of 1,682 drugs
More prescriptions than 31% of the 1,682 drugs we measure
3,300 prescriptions, Q1–Q4 2025

Patient Information Guide for Ezetimibe / Simvastatin

What It’s Used For

Ezetimibe / Simvastatin is used with diet to lower cholesterol.

  • Primary hyperlipidemia (high cholesterol), and mixed hyperlipidemia on the Ezetimibe and Simvastatin tablet label
  • Heterozygous familial hypercholesterolemia: Vytorin is approved for adults and children aged 10 and older
  • Homozygous familial hypercholesterolemia, as an add-on to other cholesterol-lowering treatments
  • Vytorin: lowering the risk of death, heart attack, stroke and artery-opening procedures in adults at high risk of coronary heart disease events (with coronary heart disease, cerebrovascular disease, peripheral vascular disease and/or diabetes)

How It Works

Cholesterol in your blood comes from food absorbed in the gut and from the liver’s own production. Ezetimibe blocks a transporter in the small intestine that takes up cholesterol. This means less cholesterol reaches the liver.

Simvastatin blocks HMG-CoA reductase, a liver enzyme needed to make cholesterol. The liver then pulls more LDL cholesterol out of the blood. Together they lower LDL cholesterol through two complementary routes.

Drug Class

Drug Class

  • Dietary Cholesterol Absorption Inhibitor from ezetimibe
  • HMG-CoA Reductase Inhibitor from simvastatin
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class. Ezetimibe / Simvastatin has two active ingredients, so each class says which one it comes from.

Drug Class

Established Pharmacologic Class (EPC)
  • Dietary Cholesterol Absorption Inhibitor from ezetimibe
  • HMG-CoA Reductase Inhibitor from simvastatin

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors from simvastatin

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)
  • Decreased Cholesterol Absorption from ezetimibe

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)

None listed for Ezetimibe / Simvastatin in the FDA’s index.

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Combinations of various lipid modifying agents

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

The tablet is taken by mouth once a day in the evening, with or without food. Your prescriber picks the strength, and your cholesterol is usually rechecked a few weeks after starting or changing the dose.

  • If you miss a dose (Vytorin), take it as soon as you can. Do not double the next dose.
  • Take it at least 2 hours before or 4 hours after a bile acid sequestrant.
  • Some medicines you take can limit your dose.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

High cholesterol

Adults Usual dose 10/10 mg to 10/40 mg once a day Highest dose 10/40 mg once daily
  • Vytorin 10/10 mg to 10/40 mg once a day, taken orally in the evening with or without food

Good to know

Vytorin 10/80 mg daily is restricted to patients who have taken it chronically (e.g., for 12 months or more) without evidence of muscle toxicity

Children 10 years and older Usual dose 10/10 mg to 10/40 mg once a day Highest dose 10/40 mg once daily
  • Vytorin 10/10 mg to 10/40 mg once a day
Adults with moderate to severe kidney problems Doses of Vytorin exceeding 10/20 mg should be used with caution and close monitoring

Good to know

No dosage adjustment recommendations for mild renal impairment

Special Situations

Patients taking lomitapide

Reduce the dosage of Vytorin by 50%

Patients taking verapamil, diltiazem, or dronedarone

Do not exceed Vytorin 10/10 mg once daily

Patients taking amiodarone, amlodipine, or ranolazine

Do not exceed Vytorin 10/20 mg once daily

See the Full Dosing Instructions on DailyMed →

Side Effects

Common side effects seen in studies include:

Common side effects

  • Headache
  • Increased liver enzyme (ALT) on blood tests
  • Muscle aches (myalgia)
  • Upper respiratory tract infection
  • Diarrhea
  • Pain in arms or legs
  • Flu

When to get medical help

  • Call your doctor promptly if you have unexplained muscle pain, tenderness or weakness, especially with fever or feeling unwell. This could be myopathy or rhabdomyolysis (serious muscle breakdown).
  • Get help if you have signs of liver problems such as yellowing of the skin or eyes (jaundice).
  • Seek urgent care for allergic reactions such as swelling of the face or throat, hives, or trouble breathing.
  • Tell your doctor if muscle weakness continues even after stopping the medicine.
  • Let your doctor know about memory loss or confusion, which has been reported rarely with statins and is generally reversible after stopping.
  • If you become pregnant, stop the medicine and call your doctor right away.

Warnings and Precautions

  • Muscle damage: myopathy and rhabdomyolysis are the main risks and rise with higher doses. The 10/80 strength is restricted to people who have long tolerated it.
  • Higher risk groups: age 65 and older, women, uncontrolled underactive thyroid, kidney problems and possibly Chinese patients.
  • Liver: enzymes can rise, and testing is advised before starting and as needed. Rare liver failure has been reported with statins.
  • Immune-mediated necrotizing myopathy: a rare autoimmune muscle condition linked to statins, with weakness that persists after stopping.
  • Your doctor may pause the medicine during serious illness, major surgery or trauma.

Interactions

Many medicines raise simvastatin levels and muscle risk, so always check before starting anything new.

  • Strong CYP3A4 inhibitors (certain antifungals, antibiotics, HIV medicines, nefazodone): not allowed with this medicine
  • Gemfibrozil, cyclosporine, danazol: not allowed
  • Grapefruit juice: avoid it
  • Verapamil, diltiazem, dronedarone, amiodarone, amlodipine, ranolazine: dose limits apply
  • Fenofibrates, niacin, colchicine: higher muscle risk, so monitoring is needed
  • Daptomycin: this medicine is usually paused temporarily
  • Lomitapide: dose is reduced
  • Bile acid sequestrants: space doses apart so ezetimibe works
  • Warfarin-type blood thinners and digoxin: blood tests are monitored

Interactions Listed in the FDA-Approved Label

From the Ezetimibe / Simvastatin prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Strong CYP3A4 inhibitors For example: itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin, clarithromycin, telithromycin, nelfinavir, ritonavir, boceprevir, telaprevir, cobicistat-containing products, nefazodone
    What happensIncreases simvastatin exposure and the risk of myopathy and rhabdomyolysis.
    What to doContraindicated; if treatment with a CYP3A4 inhibitor is unavoidable, suspend ezetimibe and simvastatin during the course of treatment.
  • Cyclosporine, danazol, or gemfibrozil
    What happensThe risk of myopathy and rhabdomyolysis is increased.
    What to doConcomitant use is contraindicated.
  • Amiodarone, dronedarone, ranolazine, or calcium channel blockers
    What happensThe risk of myopathy and rhabdomyolysis is increased.
    What to doWith verapamil, diltiazem, or dronedarone do not exceed 10/10 mg daily; with amiodarone, amlodipine, or ranolazine do not exceed 10/20 mg daily.
  • What happensSimvastatin exposure is approximately doubled and the risk of myopathy and rhabdomyolysis is increased.
    What to doReduce the dose by 50% if initiating lomitapide; do not exceed 10/20 mg daily (or 10/40 mg daily for patients who previously took 10/80 mg chronically).
  • Daptomycin
    What happensCases of rhabdomyolysis reported; both can cause myopathy and rhabdomyolysis, and risk may be increased by coadministration.
    What to doIf daptomycin is required, consider temporarily suspending ezetimibe and simvastatin during daptomycin treatment.
  • What happensCases of myopathy and rhabdomyolysis have been observed; the risk of myopathy is greater in Chinese patients.
    What to doNot recommended in Chinese patients; for others, consider whether benefit outweighs risk and monitor for signs and symptoms of myopathy.
  • Fibrates (other than gemfibrozil)
    What happensThe risk of myopathy and rhabdomyolysis is increased.
    What to doConsider if benefit outweighs risk; if used together, monitor for signs and symptoms of myopathy.
  • What happensCases of myopathy and rhabdomyolysis have been reported.
    What to doConsider if benefit outweighs risk; if used together, monitor for signs and symptoms of myopathy.
  • Grapefruit juice
    What happensCan raise plasma levels of simvastatin and may increase the risk of myopathy and rhabdomyolysis.
    What to doAvoid grapefruit juice when taking ezetimibe and simvastatin.
  • Bile acid sequestrants (cholestyramine)
    What happensCholestyramine decreased mean exposure of total ezetimibe approximately 55%, which may reduce the incremental LDL-C reduction.
    What to doAdminister ezetimibe and simvastatin at least 2 hours before or at least 4 hours after the bile acid sequestrant.
Read the label’s full interactions text

7 DRUG INTERACTIONS Ezetimibe and simvastatin tablets • See full prescribing information for details regarding concomitant use of ezetimibe and simvastatin tablets with other drugs or grapefruit juice that increase the risk of myopathy and rhabdomyolysis. • Cholestyramine: Combination decreases exposure of ezetimibe. • Coumarin Anticoagulants: Obtain INR before ezetimibe and simvastatin tablets initiation and monitor INR during ezetimibe and simvastatin tablets dosage initiation or adjustment. • Digoxin: During ezetimibe and simvastatin tablets initiation, monitor digoxin levels. • Fenofibrates: Combination increases exposure of ezetimibe. If cholelithiasis is suspected in a patient receiving ezetimibe and a fenofibrate, gallbladder studies are indicated and alternative lipid-lowering therapy should be considered. 7.1 Drug Interactions that Increase the Risk of Myopathy and Rhabdomyolysis with Ezetimibe and Simvastatin Tablets Ezetimibe and simvastatin tablets are a substrate of CYP3A4 and of the transport protein OATP1B1. ezetimibe and simvastatin tablets plasma levels can be significantly increased with concomitant administration of inhibitors of CYP3A4 and OATP1B1. Table 2 includes a list of drugs that increase the risk of myopathy and rhabdomyolysis when used concomitantly with ezetimibe and simvastatin tablets and instructions for preventing or managing them. Table 2: Drug Interactions that Increase the Risk of Myopathy and Rhabdomyolysis with Ezetimibe and Simvastatin Tablets Strong CYP3A4 inhibitors Clinical Impact: Simvastatin is a substrate of CYP3A4. Concomitant use of strong CYP3A4 inhibitors with ezetimibe and simvastatin tablets increases simvastatin exposure and increases the risk of myopathy and rhabdomyolysis, particularly with higher ezetimibe and simvastatin tablets dosages.

Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Do not use during pregnancy or if you may become pregnant. Use effective contraception, and stop right away if you become pregnant.
  • Do not use while breastfeeding.
  • Do not use with active liver disease or unexplained persistent liver enzyme elevations.
  • Do not use if allergic to any ingredient.
  • Older adults (65+) should use it with caution because of muscle risk.
  • With moderate to severe kidney problems, higher doses need caution and close monitoring.
  • Children: Vytorin is approved for ages 10 and up with heterozygous familial hypercholesterolemia.
  • Tell your doctor if you drink substantial amounts of alcohol.

Overdose

No specific treatment for overdose is recommended. Care focuses on treating symptoms and supportive measures. A few overdoses have been reported with the individual ingredients, and those people recovered without lasting effects. If you take too much, call Poison Control or seek medical help.

Half-Life and How Your Body Processes It

The combination tablet was shown to match taking ezetimibe and simvastatin as separate tablets. Ezetimibe is absorbed and converted to an active form, and its half-life is about 22 hours. Food does not change how much ezetimibe is absorbed. Simvastatin is largely cleared by the liver on first pass, and food does not affect it much. Both are mostly removed through feces, with some leaving in urine. Levels are higher in older adults.

Storage

Store at 68°F to 77°F (20°C to 25°C).

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ezetimibe / Simvastatin: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Ezetimibe / Simvastatin — the kind of thing our pharmacy team would talk through with you at the counter.

What is this medicine for?

It lowers LDL cholesterol when diet alone hasn’t been enough. That includes high cholesterol and inherited forms. Vytorin’s simvastatin is also used to reduce heart attack, stroke and related risks in some high-risk adults.

When and how should I take it?

Take one tablet by mouth in the evening, with or without food. If you miss a dose, take it as soon as you remember, but don’t double up the next one. If you take cholestyramine or a similar medicine, space them apart: this one at least 2 hours before or 4 hours after.

What side effects should I expect?

Common ones are headache, muscle aches, diarrhea, cold-like symptoms and higher liver enzymes on blood tests. Most people do fine. Tell me or your doctor if anything bothers you.

When should I call my doctor?

Call promptly for muscle pain, tenderness or weakness you can’t explain, especially with fever or feeling unwell. Also call for yellow skin or eyes, or signs of allergic reaction like swelling or trouble breathing. Muscle problems can be serious, so don’t wait.

Can I drink grapefruit juice or take other medicines with it?

Avoid grapefruit juice, because it can raise simvastatin levels. Several medicines are not allowed with this one, such as certain antifungals, antibiotics, HIV medicines, gemfibrozil and cyclosporine. Always check with me before starting anything new, even over-the-counter products.

Is it safe in pregnancy?

No. It should not be used if you are pregnant or may become pregnant, or while breastfeeding. If you become pregnant while taking it, stop and call your doctor right away.

Is ezetimibe / simvastatin available over the counter?

No. Ezetimibe / simvastatin is a prescription medicine: every ezetimibe / simvastatin product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was ezetimibe / simvastatin first available?

The earliest FDA record we hold for ezetimibe / simvastatin is from 2004: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when ezetimibe / simvastatin was first used.

Who makes ezetimibe / simvastatin?

8 companies currently list ezetimibe / simvastatin products in the FDA's NDC Directory, including Ascend Laboratories, LLC, Aurobindo Pharma Limited, Dr.Reddys Laboratories Inc. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of ezetimibe / simvastatin?

Ezetimibe / simvastatin is the generic name. Its brand name is Vytorin. Generic versions are listed under the name ezetimibe / simvastatin.

What is the generic name of Vytorin?

The generic name of Vytorin is ezetimibe / simvastatin. A generic name is the name of the active ingredients, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is ezetimibe / simvastatin?

Ezetimibe / simvastatin belongs to the drug class Dietary Cholesterol Absorption Inhibitor and HMG-CoA Reductase Inhibitor, its established pharmacologic class on the FDA label. The FDA also groups it by how it works: Hydroxymethylglutaryl-CoA Reductase Inhibitor.

Is there a generic version of ezetimibe / simvastatin?

Yes. FDA-approved generic versions of ezetimibe / simvastatin are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does ezetimibe / simvastatin come in?

Ezetimibe / simvastatin is listed in the FDA's National Drug Code Directory in these forms and strengths. Tablet (by mouth): 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg. A listing does not mean every pharmacy stocks every strength.

How much does ezetimibe / simvastatin cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $0.18 to $0.27 per generic tablet across 4 strengths and $13.71 to $13.80 per tablet of brand-name Vytorin across 2 strengths as of November 18, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Where can I read the ezetimibe / simvastatin prescribing information (package insert)?

The full FDA-approved prescribing information for ezetimibe / simvastatin, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Organon LLC's, revised Jan 21, 2026, and links to it on DailyMed.

Is ezetimibe / simvastatin gluten free?

No ezetimibe / simvastatin label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 27 ezetimibe / simvastatin products from 8 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's ezetimibe / simvastatin by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See ezetimibe / simvastatin inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Ezetimibe / Simvastatin

Skip the scrolling. Ask in your own words and get an answer from Ezetimibe / Simvastatin’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Ezetimibe / Simvastatin’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Ezetimibe / Simvastatin on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Ezetimibe / Simvastatin Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Ezetimibe / Simvastatin Forms and Strengths (How It Comes)

Ezetimibe / Simvastatin comes in 1 dose form, the tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Ezetimibe / Simvastatin inactive ingredients by manufacturer.

Tablet

By mouth
Brands Vytorin (the first brand, 2004)
How this form is used
What it may be used for
  • Ezetimibe and Simvastatin tablets are used with diet to lower cholesterol in primary or mixed hyperlipidemia and in homozygous familial hypercholesterolemia.
  • Vytorin is used to lower LDL cholesterol in adults with primary hyperlipidemia and in adults and children 10 and older with heterozygous familial hypercholesterolemia.
  • Vytorin is also used with other LDL-lowering treatments in adults with homozygous familial hypercholesterolemia.
Important instructions
  • Vytorin is taken by mouth once daily in the evening, with or without food.
  • Ezetimibe and Simvastatin tablets are taken as a single daily dose in the evening, with or without food.
  • Vytorin: if you miss a dose, take it as soon as possible and do not double the next dose.
  • Vytorin and Ezetimibe and Simvastatin tablets should be taken at least 2 hours before or 4 hours after a bile acid sequestrant.
Available strengths 4 strengths
27 FDA-listed product records ⓘ

Ezetimibe / Simvastatin on the U.S. Market: Products, Makers and Brands

How Ezetimibe / Simvastatin appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

8 companies list 27 Ezetimibe / Simvastatin product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 2004. The one brand name in the directory today is Vytorin; the rest are generics.

1
Dose forms ⓘ
8
Labelers (makers, repackagers, distributors)
1
Brand names ⓘ
27
FDA-listed product records ⓘ
2004
Earliest FDA record ⓘ

Also listed with the FDA, not a patient dose form: Unfinished tablet (8) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

Ascend Laboratories, LLC15%
Aurobindo Pharma Limited15%
Dr.Reddys Laboratories Inc15%
Glenmark Pharmaceuticals Inc., USA15%
Golden State Medical Supply, Inc.15%
Organon LLC15%
Other makers11%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Ezetimibe / Simvastatin Is Used (Medicaid Data)

How many Ezetimibe / Simvastatin prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

3,300
Medicaid prescriptions filled (Q1–Q4 2025)
$100,966 paid by Medicaid, before rebates

How commonly is Ezetimibe / Simvastatin prescribed? Of the 1,682 medications we measure, Ezetimibe / Simvastatin ranks #1,145 by Medicaid prescriptions — more than 32% of them.

Where Ezetimibe / Simvastatin ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Ezetimibe / Simvastatin product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 10 mg / 20 mg oral tablet is the most-dispensed Ezetimibe / Simvastatin product — about 41% of these Medicaid prescriptions.

ezetimibe 10 MG / simvastatin 20 MG Oral Tablet Most dispensed

1,359 Medicaid prescriptions (Q1–Q4 2025) 41% of Ezetimibe / Simvastatin prescriptions shown $40,075 paid by Medicaid, before rebates ≈ $29 per prescription, before rebates

4 of 39 listed NDCs had Medicaid claims. RxNorm 476349

ezetimibe 10 MG / simvastatin 40 MG Oral Tablet

1,329 Medicaid prescriptions (Q1–Q4 2025) 40% of Ezetimibe / Simvastatin prescriptions shown $42,163 paid by Medicaid, before rebates ≈ $32 per prescription, before rebates

6 of 40 listed NDCs had Medicaid claims. RxNorm 476350

ezetimibe 10 MG / simvastatin 10 MG Oral Tablet

419 Medicaid prescriptions (Q1–Q4 2025) 13% of Ezetimibe / Simvastatin prescriptions shown $12,411 paid by Medicaid, before rebates ≈ $30 per prescription, before rebates

3 of 36 listed NDCs had Medicaid claims. RxNorm 476345

ezetimibe 10 MG / simvastatin 80 MG Oral Tablet

193 Medicaid prescriptions (Q1–Q4 2025) 6% of Ezetimibe / Simvastatin prescriptions shown $6,317 paid by Medicaid, before rebates ≈ $33 per prescription, before rebates

2 of 35 listed NDCs had Medicaid claims. RxNorm 476351

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 15 of the 150 listed Ezetimibe / Simvastatin NDCs had Medicaid claims.

Compare Ezetimibe / Simvastatin Products

A representative set of FDA-listed product records for Ezetimibe / Simvastatin — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 27 of 27 products — FDA National Drug Code Directory. See every product, package size and price: browse all 27 Ezetimibe / Simvastatin NDCs →

Ezetimibe / Simvastatin Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Ezetimibe / Simvastatin recalls since July 2021.

✅No Ezetimibe / Simvastatin recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Ezetimibe / Simvastatin in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one exact combination of ingredients (MIN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. A different combination is a different concept with its own page.

Dose forms
1
Strengths
4
Forms in current FDA listings
1 of 1
In current FDA listings No current FDA listing
Multiple ingredients (MIN) Ezetimibe / Simvastatin RxCUI 484211
  1. Dose form (SCDF) Oral Tablet RxCUI 476348
    In current FDA listings

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Ezetimibe / Simvastatin Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Ezetimibe / Simvastatin: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick the generic or the brand and a strength to see how its price has changed since Nov 2023.

Version
Strength

For the generic EZETIMIBE 10 mg/1; SIMVASTATIN 10 mg tablet, pharmacies paid an average of $0.224 per tablet as of Nov 18, 2026, down 31% from $0.325 a year earlier.

What pharmacies pay now
$0.224
per tablet, as of Nov 18, 2026
Last 4 weeks
Down 15%
from $0.265 on Oct 21, 2026
Last 12 months
Down 31%
from $0.325 on Nov 19, 2025
Lowest and highest since Nov 2023
$0.224 to $0.574
per tablet

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Generic EZETIMIBE 10 mg/1; SIMVASTATIN 10 mg tablet: the average pharmacy price per tablet, the last survey of each month
MonthPharmacy price
Nov 2026$0.224
Oct 2026$0.265
Sep 2026$0.274
Aug 2026$0.328
Jul 2026$0.359
Jun 2026$0.381
May 2026$0.350
Apr 2026$0.327
Mar 2026$0.345
Feb 2026$0.366
Jan 2026$0.353
Dec 2025$0.335
Nov 2025$0.325
Oct 2025$0.319
Sep 2025$0.303
Aug 2025$0.264
Jul 2025$0.280
Jun 2025$0.304
May 2025$0.350
Apr 2025$0.331
Mar 2025$0.334
Feb 2025$0.325
Jan 2025$0.340
Dec 2024$0.379
Nov 2024$0.323
Oct 2024$0.456
Sep 2024$0.419
Aug 2024$0.301
Jul 2024$0.308
Jun 2024$0.374
May 2024$0.323
Apr 2024$0.380
Mar 2024$0.444
Feb 2024$0.383
Jan 2024$0.493
Dec 2023$0.427
Nov 2023$0.574
FormStrengthVersion What pharmacies pay
Tablet · Oral EZETIMIBE 10 mg/1; SIMVASTATIN 10 mg Generic $0.224 per tablet NDC details & price history
Tablet · Oral EZETIMIBE 10 mg/1; SIMVASTATIN 20 mg Generic $0.181 per tablet NDC details & price history
Tablet · Oral EZETIMIBE 10 mg/1; SIMVASTATIN 20 mg Vytorin (brand) $13.71 per tablet NDC details & price history
Tablet · Oral EZETIMIBE 10 mg/1; SIMVASTATIN 40 mg Generic $0.196 per tablet NDC details & price history
Tablet · Oral EZETIMIBE 10 mg/1; SIMVASTATIN 40 mg Vytorin (brand) $13.80 per tablet NDC details & price history
Tablet · Oral EZETIMIBE 10 mg/1; SIMVASTATIN 80 mg Generic $0.236–$0.273 per tablet NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Ezetimibe / Simvastatin Brand Names

Ezetimibe / Simvastatin has one brand name on record: Vytorin. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Vytorin the first brand, 2004

Who Makes Ezetimibe / Simvastatin: Manufacturers and Labelers

8 companies list Ezetimibe / Simvastatin products with the FDA. By number of product records, the largest are Ascend Laboratories, LLC, Aurobindo Pharma Limited, Dr.Reddys Laboratories Inc. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Ascend Laboratories, LLC 4 Aurobindo Pharma Limited 4 Dr.Reddys Laboratories Inc 4 Glenmark Pharmaceuticals Inc., USA 4 Golden State Medical Supply, Inc. 4 Organon LLC 4 A-S Medication Solutions 2 Northstar Rx Llc 1

Sources for This Ezetimibe / Simvastatin Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Jan 21, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Ezetimibe / Simvastatin.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 10 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
10
Finished products in the current FDA directory
27
Companies listing them (makers, repackagers, distributors)
8
FDA labeler codes behind them ⓘ
8
Linked representative label ⓘ
Organon LLC
Linked label effective
Jan 21, 2026
Composite sections available
23
Linked SPL Set ID
89b860d2-de83-468e-b7e8-76aeec2edca2
Linked SPL Document ID
9e668c78-ea5d-4099-ba16-b77aebbcb68a
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Organon LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →